Amy Xu

1.1k total citations
40 papers, 435 citations indexed

About

Amy Xu is a scholar working on Cancer Research, Oncology and Surgery. According to data from OpenAlex, Amy Xu has authored 40 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cancer Research, 13 papers in Oncology and 11 papers in Surgery. Recurrent topics in Amy Xu's work include Breast Cancer Treatment Studies (19 papers), Advanced Radiotherapy Techniques (7 papers) and Brain Metastases and Treatment (5 papers). Amy Xu is often cited by papers focused on Breast Cancer Treatment Studies (19 papers), Advanced Radiotherapy Techniques (7 papers) and Brain Metastases and Treatment (5 papers). Amy Xu collaborates with scholars based in United States, China and Hungary. Amy Xu's co-authors include Timothy A. Springer, Erin F. Gillespie, Simon N. Powell, Oren Cahlon, Atif J. Khan, Lior Z. Braunstein, Beryl McCormick, John Cuaron, Boris Mueller and Jonathan T. Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Amy Xu

34 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Xu United States 10 154 90 90 90 81 40 435
Patricia Daly Ireland 9 96 0.6× 62 0.7× 68 0.8× 40 0.4× 34 0.4× 19 312
Séan M. O’Cathail United Kingdom 14 222 1.4× 138 1.5× 93 1.0× 45 0.5× 49 0.6× 45 486
Santanu Samanta United States 12 84 0.5× 157 1.7× 105 1.2× 79 0.9× 107 1.3× 25 453
Rajnish Nagarkar India 12 246 1.6× 141 1.6× 132 1.5× 59 0.7× 29 0.4× 61 665
Wenxin Luo China 11 117 0.8× 258 2.9× 132 1.5× 65 0.7× 66 0.8× 29 645
Ulrika Hansson Sweden 15 167 1.1× 111 1.2× 93 1.0× 96 1.1× 38 0.5× 16 607
Mohan Hingorani United Kingdom 17 382 2.5× 269 3.0× 206 2.3× 109 1.2× 71 0.9× 39 1.1k
Kirti Srivastava India 14 117 0.8× 103 1.1× 81 0.9× 46 0.5× 74 0.9× 61 601
Klaudia Szymonowicz United States 8 126 0.8× 232 2.6× 95 1.1× 38 0.4× 83 1.0× 9 483
Anne Rodallec France 14 138 0.9× 162 1.8× 34 0.4× 59 0.7× 35 0.4× 26 525

Countries citing papers authored by Amy Xu

Since Specialization
Citations

This map shows the geographic impact of Amy Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Xu more than expected).

Fields of papers citing papers by Amy Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Xu. The network helps show where Amy Xu may publish in the future.

Co-authorship network of co-authors of Amy Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Xu. A scholar is included among the top collaborators of Amy Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Xu. Amy Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nelson, Blessie Elizabeth, Shaun O’Brien, Rahul A. Sheth, et al.. (2025). Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors. Journal for ImmunoTherapy of Cancer. 13(1). e010013–e010013. 6 indexed citations
2.
3.
Tadros, Audree B., Brian Diskin, Varadan Sevilimedu, et al.. (2025). Trends in Guideline-Concordant Care for Inflammatory Breast Cancer. JAMA Network Open. 8(2). e2454506–e2454506. 5 indexed citations
4.
Gilliland, Jaime, et al.. (2024). A Qualitative Exploration of Sacred Moments in Radiation Oncology. Advances in Radiation Oncology. 9(11). 101617–101617. 2 indexed citations
5.
6.
Braunstein, Lior Z., Boris Mueller, John Cuaron, et al.. (2024). Accelerated Partial Breast Irradiation for Early-Stage Invasive Lobular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 121(4). 894–899. 1 indexed citations
7.
Lee, Joyce Y., et al.. (2024). Artificial intelligence in applied family research involving families with young children: A scoping review. Family Relations. 74(3). 1121–1145. 4 indexed citations
8.
Narayan, Priyanka, Zhigang Zhang, Boris Mueller, et al.. (2023). Metaplastic carcinoma of the breast: matched cohort analysis of recurrence and survival. Breast Cancer Research and Treatment. 199(2). 355–361. 5 indexed citations
9.
Flynn, Jessica, Zhigang Zhang, Erin F. Gillespie, et al.. (2023). Locoregional Control Benefit of a Tumor Bed Boost for Ductal Carcinoma In Situ. Advances in Radiation Oncology. 8(5). 101254–101254. 1 indexed citations
10.
Fiasconaro, Megan, Zhigang Zhang, Beryl McCormick, et al.. (2023). Accelerated Partial Breast Irradiation: Association of Dosimetric Parameters With Patient-Reported Outcomes. Advances in Radiation Oncology. 8(6). 101263–101263.
11.
Montagna, Giacomo, Boris Mueller, Fumiko Chino, et al.. (2023). Accelerated Partial Breast Irradiation for HER2-Positive Early-Stage Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 118(2). 468–473. 2 indexed citations
12.
Freret, Morgan E., N. Ari Wijetunga, A. Shamseddine, et al.. (2022). Early Detection of Leptomeningeal Metastases Among Patients Undergoing Spinal Stereotactic Radiosurgery. Advances in Radiation Oncology. 8(2). 101154–101154. 2 indexed citations
13.
Narayan, Priyanka, Jessica Flynn, Zhigang Zhang, et al.. (2021). Perineural invasion as a risk factor for locoregional recurrence of invasive breast cancer. Scientific Reports. 11(1). 12781–12781. 28 indexed citations
14.
Nasir, Muhammad Umer, et al.. (2020). How well do we represent ourselves: an analysis of musculoskeletal radiology fellowships website content in Canada and the USA. Skeletal Radiology. 49(12). 1951–1955. 6 indexed citations
15.
Xu, Amy, Leo Y. Luo, Jonathan E. Leeman, et al.. (2020). Beyond reirradiation: Efficacy and safety of three or more courses of radiation for head and neck malignancies. Clinical and Translational Radiation Oncology. 23. 30–34. 4 indexed citations
16.
Yerramilli, Divya, Amy Xu, Erin F. Gillespie, et al.. (2020). Palliative Radiation Therapy for Oncologic Emergencies in the Setting of COVID-19: Approaches to Balancing Risks and Benefits. Advances in Radiation Oncology. 5(4). 589–594. 38 indexed citations
17.
Braunstein, Lior Z., Erin F. Gillespie, Linda Hong, et al.. (2020). Breast Radiation Therapy Under COVID-19 Pandemic Resource Constraints—Approaches to Defer or Shorten Treatment From a Comprehensive Cancer Center in the United States. Advances in Radiation Oncology. 5(4). 582–588. 81 indexed citations
18.
Chen, I., Astrid Botty van den Bruele, Erin F. Gillespie, et al.. (2020). Salvage of Locally Recurrent Breast Cancer with Repeat Breast Conservation Using 45Gy Hyperfractionated Partial Breast Re-Irradiation. International Journal of Radiation Oncology*Biology*Physics. 108(3). e41–e42. 1 indexed citations
19.
Xu, Amy, Carl J. DeSelm, Alice Y. Ho, et al.. (2019). Overall Survival of Breast Cancer Patients With Locoregional Failures Involving Internal Mammary Nodes. Advances in Radiation Oncology. 4(3). 447–452. 8 indexed citations
20.
Xu, Amy & Timothy A. Springer. (2013). Mechanisms by which von Willebrand Disease Mutations Destabilize the A2 Domain*. Journal of Biological Chemistry. 288(9). 6317–6324. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia Daly Breakdown of academic impact, for papers by Séan M. O’Cathail Breakdown of academic impact, for papers by Santanu Samanta Breakdown of academic impact, for papers by Rajnish Nagarkar Breakdown of academic impact, for papers by Wenxin Luo Breakdown of academic impact, for papers by Ulrika Hansson Breakdown of academic impact, for papers by Mohan Hingorani Breakdown of academic impact, for papers by Kirti Srivastava Breakdown of academic impact, for papers by Klaudia Szymonowicz Breakdown of academic impact, for papers by Anne Rodallec
Rankless by CCL
2026